Day: April 30, 2020

AB “Ignitis gamyba” (hereinafter referred to as the Company) company code 302648707, registered office  at Elektrinės st. 21, Elektrėnai. The total number of registered ordinary shares issued by the Company is 648 002 629; ISIN code LT0000128571.The Company informs that on 29 April 2020 it received the report of Ignitis Grupė, UAB, on the implementation of the tender offer for shares of ESO (hereinafter – the Report).The Report indicates that during the period of the official tender offers, which lasted from 3 April 2020 to 22 April 2020, 4 081 833 (four million eighty-one thousand eight hundred and thirty-three) shares of GEN were buyout, which equals to 0.63 % of the authorized capital of the Company.After the official tender offer for shares of GEN, Ignitis Grupė, UAB, owns 97.45% of the shares of the Company, other shareholders owns...

AB „Ignitis gamyba“, kodas 302648707, registruotos buveinės adresas Elektrinės g. 21, LT-26108 Elektrėnai, Lietuvos Respublika (toliau – ir GEN). Bendras AB „Ignitis gamyba“ išleistų paprastųjų vardinių akcijų skaičius yra 648 002 629; ISIN kodas – LT0000128571.Bendrovė informuoja, kad 2020 m. balandžio 29 d. iš UAB „Ignitis grupė“ sulaukė ataskaitos dėl nekonkurencinio oficialaus siūlymo dėl GEN akcijų įgyvendinimo (toliau – Ataskaita).Ataskaitoje nurodoma, kad oficialaus siūlymo laikotarpiu nuo 2020 m. balandžio 3 d. iki 2020 m. balandžio 22 d. buvo supirkta 4 081 833 (keturi milijonai aštuoniasdešimt vienas tūkstantis aštuoni šimtai trisdešimt trys) GEN akcijos. Jos sudaro 0,63 proc. Bendrovės įstatinio kapitalo.Pasibaigus oficialiam siūlymui dėl GEN akcijų, UAB „Ignitis grupė“ priklauso 97,45 proc. Bendrovės akcijų, 2,55 proc. akcijų...

SAN FRANCISCO, April 30, 2020 (GLOBE NEWSWIRE) — Collective Health and One Medical (Nasdaq: ONEM) recently collaborated on a peer-reviewed study published in JAMA Network Open to quantify the value delivered by a membership-based primary care model combining virtual, near-site and work-site care at one of the companies’ shared client—an American aerospace manufacturer and technology company.This peer-reviewed study specifically analyzes the effectiveness of employer participation in an integrated primary care delivery model that includes virtual, near-site and work-site care. Past studies exploring workplace health programs have been limited to occupational health services, rather than comprehensive primary care that can be used for chronic disease management, behavioral health, and other major medical needs.Key findings include:Members...

NEW YORK, April 30, 2020 (GLOBE NEWSWIRE) — World Health Energy Holdings, Inc. (OTC PINK: WHEN), a holding company with an algae-tech business and various software technology businesses with corporate offices in Boca Raton, Florida and Ramat Gan, Israel, announced today that the Company has completed a reverse merger with SG 77, Inc. a Delaware Corporation, and RNA Ltd., an Israeli company and a wholly-owned subsidiary of SG 77. SG 77 and RNA Ltd will operate as subsidiaries of the Company. Details of the merger agreement and other relevant materials can be viewed in the Company’s Current Report on Form 8-K filed on April 30, 2020.SG 77 and RNA Ltd. are a diversified cybersecurity enterprise. RNA Ltd. is a B2C and B2B software cybersecurity company that designs, develops and markets data security software based solutions....

April 30, 2020 11:09 ET | Source: IDIidi  INVESTIR EN PRIVATE EQUITY    IDI CONFIRME LE RENOUVELLEMENT DE SON ELIGIBILITE AU DISPOSITIF PEA-PME   Paris, le 30 avril 2020 – IDI, société d’investissement cotée spécialisée dans les entreprises du mid market, confirme le renouvellement de son éligibilité au dispositif PEA-PME pour 2020-2021 conformément au décret n°2014-283 du 4 mars 2014, puisqu’elle dispose de moins de 5 000 salariés, d’une part, et d’un chiffre d’affaires annuel inférieur à 1 500 millions d’euros et d’un total de bilan inférieur à 2 000 millions d’euros, d’autre part. En conséquence, les actions de l’IDI peuvent être intégrées au sein des comptes PEA-PME qui bénéficient des mêmes avantages fiscaux que le plan d’épargne en actions (PEA) traditionnel. A propos de l’IDI : L’IDI,...

Bagsværd, Denmark, 30 April 2020 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.Referring to Company Announcement no 25/2020 dated 28 April 2020, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 30 April 2020.1 Each A share of DKK 0.01 carries 10 votes, whereas each B share of DKK 0.01 carries one vote. Thus, each A share of DKK 0.20 carries 200 votes and each B share of DKK 0.20 (the present denomination of the company’s shares) carries 20 votes. Treasury shares are included in the table above but voting rights of treasury shares are suspended at the general...

Volta Finance Limited (VTA/VTAS)Half-Yearly Financial Reportfor the period from 1 August 2019 to 31 January 2020NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTOTHE UNITED STATES*****Guernsey, 30 April 2020Volta Finance Limited has published its results for the six month period ended 31 January 2020. The half-yearly financial report is attached to this release and will be available on Volta Finance Limited’s website shortly (www.voltafinance.com).For further information, please contact:Company Secretary and Portfolio AdministratorBNP Paribas Securities Services S.C.A, Guernsey Branchguernsey.bp2s.volta.cosec@bnpparibas.com +44 (0) 1481 750 853Corporate BrokerCenkos Securities plcAndrew WorneDaniel BalabanoffRob Naylor+44 (0) 20 7397 8900For the Investment ManagerAXA Investment Managers ParisSerge Demayserge.demay@axa-im.com*****ABOUT...

Treasury shares and total voting rights corrected from previous announcement at 15:14 on 30 April 2020Issue of Equity and Total Voting Rights and CapitalKINGS ARMS YARD VCT PLCLEI Code 213800DK8H27QY3J5R45The first and final allotment for the 2020/2021 tax year of new ordinary shares of nominal value 1 penny per share in Kings Arms Yard VCT PLC (the “Company”) under the Albion VCTs Prospectus Top Up Offers 2019/20 (the “Offers”), (which was launched on 22 October 2019) took place on 30 April 2020.Pursuant to the Prospectus, the Company offered an early bird discount of 1% on issue costs to existing shareholders and 0.5% on issue costs to new subscribers. These early bird discounts were available to investors who subscribed for new shares for the first £10m by 2 p.m. on 31 January 2020 across the five VCTs participating in the Offers. The...

IQE plc(“IQE” or the “Company”)Total Voting Rights    30 April 2020As at 30 April 2020, the Company’s issued share capital consisted of 796,455,882 ordinary shares of 1 pence each (“Ordinary Shares”). All of these Ordinary Shares carry voting rights of one vote per Ordinary Share. The Company holds no Ordinary Shares in treasury.The total number of voting rights in the Company is therefore 796,455,882.The above figures  may  be  used  by  shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.Contacts:IQE plc (+44 29 2083 9400)Amy Barlow         Peel Hunt LLP (Nomad and Joint Broker)+44 (0) 20 7418 8900Edward KnightNick Prowting